ArticleFrontiers in cardiovascular medicine2022

Clinical outcomes of subcutaneous vs. transvenous implantable defibrillator therapy in a polymorbid patient cohort.

Badder Kattih et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.